which are generally regarded as the products of single cell clones may have invariant amino acid sequences. In syndromes associated with antibody deficiency there is not uncommonly a selective decrease of one or other of the major immunoglobulin classes (Table 4 ). It is evident from these examples that certain pathological lesions may be associated with a selective proliferation or suppression of particular immunoglobulin-producing cells. The factors which regulate such differential reactivity are clearly of fundamental importance in the immune response but their identity is at present quite obscure.
Dr J H Humphrey (National Institute for Medical Research, London)
The Biological Properties of Immunoglobulins
The existence of multiple classes and subclasses of immunoglobulins in every mammalian species in which they have been carefully sought is unlikely to be explained by the need for diversity of antibody combining sites. In the first place, as Professor Cohen has explained, the differences between one immunoglobulin class and another, and between at least some of the subclasses, have been shown to depend upon the Fc portion of the heavy chain, which is not associated with the combining site. In the second place antibodies with similar specificities can often be shown to occur simultaneously among three or even four classes of immunoglobulin in the same serum sample. A particularly striking example is the demonstration of antibodies to ox insulin in the IgG, IgA and IgM of a human subject sensitized to insulin (Yagi et al. 1963 ). The example is a good one because bovine insulin has very few potential antigenic determinants for man, and in fact the antibodies elicited often behave as though directed against a single determinant group on the molecule (Berson & Yalow 1962) . Despite the observation that antibodies in a given individual elicited by an -immunogen with a very limited variety of antigenic determinants (such as Rh or dextran or salmonella 'O' antigens) may be found to be restricted to certain immunoglobulin subclasses or allotypes, there is no constant pattern of restriction from one individual to another such as would regularly associate production of a particular kind of immunoglobulin with a particular kind of antigenic determinant.
It is a plausible hypothesis that the multiplicity of immunoglobulin classes is due to their possessing different biologicalrather than immunologicalproperties which either have now, or during the course of their evolution have had, sufficient survival value for the species to ensure their continued selection. Our knowledge of the biological properties of different immunoglobulins is only rudimentary. This is not surprising since the antisera required for recognizing them have only recently become available, are often in short supply and in some cases probably remain to be discovered. However, in so far as the frequency of occurrence of different myeloma proteins appears to correlate rather well with the prevalence of corresponding immunoglobulins in normal serum when tested by the markers (such as allotypes) which we can already recognize, and in so far as the great majority of myeloma proteins are already assignable to known classes and subclasses of immunoglobulins, it seems unlikely that in man many more classes remain to be recognized.
A summary of some known biological properties of different classes is given below. For the sake of simplicity it is restricted to human immunoglobulins, though it must be recognized that some of these properties are deduced from analogy with those of apparently analogous classes in other species. The lists are not comprehensive and are intended to supplement the information given by Professor Cohen (p 589). IgG (yG) is the most abundant immunoglobulin class and in it are mainly represented the antibodies of relatively high avidity stimulated by natural infection or artificial immunization with viruses or bacteria and their products. Such antibodies are distributed in the blood and in tissue fluids roughly equally in proportion to the protein content of these fluids. They are broken down slowly and persist for many days after appearing in the blood stream. They cross the placenta from mother to fcetus, and are presentthough not selectively concentratedin milk, saliva, nasal and bronchial secretions. In fact they are almost ubiquitous, except in the cerebrospinal fluid. The antibody molecules have two identical combining sites each at the end of an arm (the Fab portions) attached flexibly to the Fc portion, so that the molecules can take up either rod-like or Y-shaped configurations. Thus they can either form cross-links between similar antigenic sites on different molecules or cells, or can attach to two similar sites (provided that these are close enough together) on the surface of a single cell or even of a very large antigen molecule. IgG antibody molecules aggregated, and probably distorted by combination with antigen activate the first component of complement and initiate the process of complement fixation. This depends on some property of the Fc portion. An important stage in this process is reached when C'3 is activated, since this leads to the phenomenon of immune adherence and increased ease of phagocytosis. When activation proceeds as far as C'7 chemotactic activity for polymorphonuclear leucocytes appears. When IgG antibody is directed against a cell surface and the full sequence of complement activation takes place (up to C'9) the surface lipid layer is disturbed and 'holes' visible in the electron microscope are formed, leading to loss of osmotic properties and death of the cell (Humphrey & Dourmashkin 1965, and unpublished) . There is evidence that two molecules of IgG antibody must become attached to a cell surface very close together for complement activation to occur. If, as is commonly the case, antigenic sites are distributed all over the cell surface this implies that quite a large number of antibody molecules (hundreds or thousands) must be attached so as to cause complement-dependent cell lysis. For this particular purpose, therefore, the IgG antibodies are not particularly efficient, but they seem to be ideally adapted for, neutralizing exotoxins or viruses, or for promoting phagocytosis. Professor Coombs mentions that in the guinea-pig y2 antibodies include some that are cytophilic for macrophages. I do not know whether the same phenomenon is observable in man, nor to what class such cytophilic antibodiesif they existbelong. We have little or no idea about the biological significance of the different IgG subclasses, though it is known that the y2a subclass differs from the rest in not being able to elicit anaphylactic reactions in the guinea-pig. I rather expect that there will sooner or later be discovered differences in their reactivity in some important respects, such as power to cause inflammation, or to attach to biologically important membranes, or to interact with antibody-producing cells to elicit the feed-back inhibition mechanism described inter alia by Rowley & Fitch (1964) .
IgM(yM) antibodies are now recognized as being regular concomitants of almost all specific antibody responses as well as being present as so-called 'natural' antibodies. They are usually detectable slightly earlier than IgG antibodies, and are initially as abundant as these. Except in the response to certain particulate antigens, such as the 'O' antigens of Gram-negative bacteria, the IgM antibodies are usually soon swamped by the production of much greater amounts of IgG antibodies, and their possible importance has tended to be overlooked. They do, however, have special properties of recognizable potential biological value. These properties derive from their possession of multiple antigen combining sites. Present evidence suggests that there are at least five identical such combining sites, and there may be more, in the molecules which consist of ten heavy and ten light chains linked to each other by disulphide bonds (Miller & Metzger 1965 , Onoue et al. 1965 ). This makes these molecules exceptionally suitable for attaching to the surfaces of cells which have large numbers of similar antigenic sites (such as 'O' antigens on bacteria or Forssman antigens on sheep erythrocytes) close enough together for the multiple combining groups to interact with the surface. Even though the association constant for each combining site may be relatively small the overall result will be a remarkably firm combination. Since there is good evidence that a single attached molecule oi IgM antibody is able to activate complement and damage cell surfaces (Humphrey & Dourmashkin 1965 , Borsos & Rapp 1965 , it seems likely that such antibodies confer a definite biological advantage, by virtue of their early production and their efficiency in opsonizing and killing extracellular invading microbes. However, large multivalent antibodies, especially if the individual combining groups are of low avidity, are likely to be not only clumsy but also ineffective when it comes to interacting with relatively small molecules such as exotoxins. Robbins and his colleagues have indeed shown that IgM antibodies may be hundreds to thousands of times more effective than IgG antibodies in opsonization and protection experiments with bacteria, but less effective in neutralizing diphtheria toxin (e.g. Robbins 1965 ). Such considerations suggest at least a partial explanation for the retention of the phylogenetically more primitive IgM antibody response despite the later evolution of the other classes. There is also evidence from mice for the existence of IgM antibodies which attach to macrophages and endow them with a much enhanced capacity to kill virulent strains of salmonella, but this has not been shown for man.
In humans, who develop potent IgM isoantibodies against erythrocytes, it would evidently be disastrous for such antibodies to pass from mother to foetus, and it is not surprising that they do not do so. Interestingly enough in rabbits and chickens, which do not normally make isoantibodies of this kind, some transfer of IgM to the feetus takes place.
IgA (yA) antibodies have only lately come into prominence, as antisera for recognizing them have become available. They also possess subclasses about whose special properties little is known. The most striking recent discovery about IgA antibodies is that, as well as occurring to a variable extent in plasma, they are present in a variety of secreted fluids such as saliva and colostrum (e.g. Tomasi et al. 1965) , and that cells synthesizing them are extremely abundant in the intestinal mucosa (Crabbe et al. 1965 ). The secreted but not the plasma IgA commonly occurs in a polymeric form associated with a distinct protein synthesized locally and apparently involved in transport of the immunoglobulin (South et al. 1966) . There is a suggestion that IgA antibodies themselves can be synthesized in apocrine glands, since IgA antibody with specificity for human blood group A has been found in colostrum while absent from the corresponding serum (Adinolfi, Mollison, Polley & Rose 1966) . IgA antibodies do not fix complement. They have been shown nevertheless by Adinolfi, Glynn, Lindsay & Milne (1966) to lyse bacteria in the presence of lysozyme, and it is probably no accident that secretions containing IgA are rich in this enzyme. It seems probable that such antibodies provide a useful protection to mucous surfaces, and that we must look again at the possible significance of the once popular but lately neglected 'copro-antibodies'. Since IgA antibodies are more resistant than IgA or IgM to the action of proteolytic enzymes and to disulphide bond reducing agents they may be well suited for such a protective role. IgD (yD) antibodies have not yet been demonstrated to my knowledge, and the biological function of this class of immunoglobulin is still a complete mystery.
IgE antibodies form a new class for whose existence there is strong presumptive evidence but for whose real existence evidence has only recently come forward from the work of Ishizaka and his colleagues (Ishizaka et al. 1966) and whose identification is still tentative. They were discovered during attempts to isolate reaginic antibodies, the heat labile skin sensitizing antibodies responsible for the anaphylactic type of immediate hypersensitivity. Such antibodies have been notoriously difficult to separate from those of other classes, especially IgA. However, Ishizaka et al. succeeded first in showing that antisera specific for the heavy chains of IgG, 1gM, IgA and IgD did not affect the activity of reaginic antibodies, and then in preparing antisera against a selected yl1 globulin fraction which could react specifically with anti-ragweed reaginic antibodies while not affecting any of the other known classes. Since the reaginic antibodies would react with antisera against light chains (and were therefore typical immunoglobulins in this respect) the presumption is that they differ from other Ig classes by virtue of their heavy chains.
Apart from their capacity to fix to tissues and to cause mast cell damage on interaction with antigen we know little about reaginic antibodies. However, similar heat labile antibodies occur in rodents, dogs and rabbits, and the rodent antibody at least can attach to isolated mast cells in vitro (J H Humphrey, unpublished) . All such antibodies may be homocytophilic for mast cells, though to state this is not to assign to them a useful biological function! While frankly admitting that we do not know what their function is, it may be relevant to point to their very marked association with helminth infections and to the possibility that reaginic antibodies have a protective role in these (see review by Bloch, 1966) . I have already stated that the subject of the biological function of the various immunoglobulin classes and subclasses is in its infancy. However, given the antisera and the methods for identifying these I hope that some Members of this Section will help the subject to grow up.
Professor R R A Coombs (Department ofPathology, University ofCambridge)

Cell-bound Antibodies
Cell-bound antibody is a designation I would hesitate to employ because of the ambiguity due to its frequent indiscriminate use in attempting to describe the unknown mechanisms of cellular immunity and hypersensitivity. In reactions such as those underlying delayed-type hypersensitivity, where no passive transfer can be achieved with serum antibody, the 'antibody' responsible is said to be 'cell-bound'. The term has too frequently been used as a cloak for ignorance, but now with the increasing elucidation of immunological mechanisms more precision can be demanded of terms and definitions.
Basically, one can consider three categories of 'cell-bound antibody'. Firstlyand simply to exclude it from this discussionred cells of a patient with acquired haemolytic anemia or of an infant with hemolytic disease of the new-born are 'sensitized' or have 'cell-bound antibody' on them as they circulate. I mention this category simply to illustrate the poor definition in this term.
It is the other two categories that bear discussion here. During immunization certain cells of the lymphoreticular system start producing specifically reacting molecules, some of which are secreted as antibody y-globulin into the lymph and blood stream; other specifically reacting molecules probably remain part of the cell; this may possibly be a stage in the process of ultimate dissociation of the molecules into free antibody or it may be quite a distinct process. In either case the cells involved can be thought of as actively allergized cells and as possessing 'cell-bound antibody' (see Fig 1) . In contrast to this, cells may be passively allergized, i.e. they adsorb antibody passively from the circulation and this bestows secondarily some specific reactivity on the cells. Such cells also have 'cell-bound antibody'. Two particular examples of such 'cell-bound antibodies' will be mentioned.
Passively Allergized Cells Antibodies concerned in anaphylactic sensitization: It has long been accepted that in anaphylactic sensitization the cells are 'passively sensitized', i.e. antibody is bound passively (not actively via its antibody receptor groups). As a consequence of reaction with antigen a chain of events is set in motion resulting in liberation from these cells of pharmacologically-active substances which dictate the clinical syndrome of anaphylaxis.
Of special interest for the present discussion are: (1) The particular immunoglobulin class capable of this passive binding or adsorption; this is discussed by Dr Humphrey.
(2) The cell types adsorbing selectively this immunoglobulin.
(3) The process by which a reaction at the cell membrane brings about release of the pharmacological mediators, some of which probably reside within lysosomes.
It is certain that histamine is released from mast cells and blood basophils, but it is not absolutely certain that this is the cell, or the only cell, involved in selective passive absorption of anaphylactic antibody. Most in vitro studies (e.g. Humphrey & Mota 1959) have been performed on mesentery tissue containing mast cells and not on isolated mast cells. But a recent study by Movat et al. (1966) 
